Delivery Order SPE2DB20D1100-SPE2DB24FB2Q2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $3,456.00 for the provision of a pharmaceutical product, specifically Ketorolac 0.5% ophthalmic solution. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of May 21, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.00 firm fixed-price delivery order is for the supply of Ketorolac 0.5% ophthalmic solution 5ml. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- This federal contract award, valued at $4,911.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 0.5% Ophthalmic Solution, a medication used to treat eye pain and inflammation. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award is a delivery order with a firm fixed price of $1,125.12 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566736695 - Ketorolac 0.5% Ophthalmic Solution, 5 mL, with a period of performance through December 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies. The $1,626.86 Firm Fixed Price contract is for the delivery of Ketorolac 0.5% ophthalmic solution, a medication used to treat eye pain and inflammation. This contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense...
- This federal contract award, valued at $7,081.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Ketorolac 0.5% ophthalmic solution, a prescription eye drop medication, with a performance period through February 3, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ketorolac 30 mg/mL vials. The $3,134.03 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, which has no set-aside designation, has an ultimate completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 10 ml bottles of Ketorolac 0.5% ophthalmic solution, with a ceiling value of $1,154.81 and a completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB2Q2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to DLA facilities worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs. This specific contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 4/15/24 |